5 de outubro de 2021 • 1 minute read
Understanding AI and its use in drug discovery
DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.
